Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Irene Losada-Galván"'
Autor:
Adriana González Martínez, Irene Losada-Galván, Juan Carlos Gabaldón-Figueira, Nieves Martínez-Peinado, Roberto Magalhães Saraiva, Marisa Liliana Fernández, Janine M Ramsey, Oscar Noya-González, Belkisyole Alarcón de Noya, Alejandro Gabriel Schijman, Soledad Berón, Marcelo Abril, Joaquim Gascón, Sergio Sosa-Estani, María Jesús Pinazo, Julio Alonso-Padilla, Alejandro Marcel Hasslocher-Moreno, NHEPACHA network (Nuevas Herramientas para el diagnóstico y la evaluación del paciente con enfermedad de Chagas)
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 8, p e0012364 (2024)
The NHEPACHA Iberoamerican Network, founded on the initiative of a group of researchers from Latin American countries and Spain, aims to establish a research framework for Chagas disease that encompasses diagnosis and treatment. For this purpose, the
Externí odkaz:
https://doaj.org/article/57de3893f01f4537ae8dd4c2298cb661
Autor:
Maria-Jesus Pinazo, Colin J. Forsyth, Constanza Lopez-Albizu, Margarita María Catalina Bisio, Adriana González-Martínez, Laura Bohorquez, Jimy Pinto, Israel Molina, Andrea Marchiol, Rafael Herazo, Irene Losada Galván, Tayná Marques, Fabiana Barreira, Juan Carlos Villar, Yanina Sguassero, Maria Soledad Santini, Jaime Altcheh, Belkisyolé Alarcón de Noya, Sergio Sosa-Estani
Publikováno v:
Frontiers in Parasitology, Vol 2 (2023)
Trypanosoma cruzi infection is diagnosed by parasitological, molecular, and serological tests. Molecular methods based on DNA amplification provide a more sensitive alternative to classical parasitological techniques for detecting evidence of T. cruz
Externí odkaz:
https://doaj.org/article/b8bcff92341a4f9aa511d461f2c45320
Autor:
María-Jesús Pinazo, Irene Losada Galván, Aina Casellas, Natalia Rodriguez-Valero, Carme Subirà, Giuseppe Gariup
Publikováno v:
Medicina Clínica (English Edition). 157:64-67
Objectives Given the scarcity of data regarding prevalence of various infectious diseases in Latin-American countries, our study aims to assess the burden of T. cruzi, S. stercoralis, HIV and viral hepatitis in Latin-American migrants, with a focus o
Autor:
Julio Alonso-Padilla, Cristina Alonso-Vega, Joaquim Gascon, Nuria Cortes-Serra, Irene Losada Galván, María-Jesús Pinazo
Publikováno v:
Expert Review of Anti-infective Therapy. 19:547-556
Introduction Chagas disease affects 6 - 7 million people, mainly in the Americas, and benznidazole is one of the two therapeutic options available. Trypanocide treatment aims to eliminate the parasite from the body to prevent the establishment or pro
Autor:
Juan María Herrero-Martínez, Olaya Madrid Pascual, Irene Losada Galván, Ana Pérez-Ayala, Manuel Lizasoain Hernández
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Am J Trop Med Hyg
Recercat. Dipósit de la Recerca de Catalunya
instname
Universidad de Barcelona
Am J Trop Med Hyg
Recercat. Dipósit de la Recerca de Catalunya
instname
In this retrospective cohort study, we aimed to assess whether introducing benznidazole at escalating doses reduces the probability of adverse events or treatment discontinuation compared with a full-dose scheme. We collected data from patients who h
Autor:
Nieves Martínez-Peinado, Juan Carlos Gabaldón-Figueira, Roberto Rodrigues Ferreira, María Carmen Thomas, Manuel Carlos López, Tania Cremonini Araújo-Jorge, Belkisyolé Alarcón de Noya, Soledad Berón, Janine Ramsey, Irene Losada Galván, Alejandro Gabriel Schijman, Adriana González Martínez, Andrés Mariano Ruiz, Gimena Rojas, Roberto Magalhães Saraiva, Oscar Noya-González, Andrea Gómez, Rosa A Maldonado, Jimmy Pinto, Faustino Torrico, Ivan Scandale, Fernán Agüero, María-Jesús Pinazo, Joaquim Gascón, Alejandro Marcel Hasslocher-Moreno, Julio Alonso-Padilla, NHEPACHA Network (New Tools for the Diagnosis and Evaluation of Chagas Disease)
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 8, p e0012166 (2024)
Chagas disease, caused by the parasite Trypanosoma cruzi, affects over 6 million people, mainly in Latin America. Two different clinical phases, acute and chronic, are recognised. Currently, 2 anti-parasitic drugs are available to treat the disease (
Externí odkaz:
https://doaj.org/article/542e8f3288c8497496fa6fd2380b1886
Autor:
Irene Losada Galván, Magdalena García, Alejandro Marcel Hasslocher-Moreno, Ariadna Ortiga, Sergi Sanz, Israel Molina, Joaquim Gascón, Maria-Jesus Pinazo
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 8, p e0012367 (2024)
Chagas disease (CD) is recognized as one of the 20 neglected tropical diseases by the World Health Organization (WHO), posing a significant global health challenge. The objective of this work was to conduct a systematic methodology review to explore
Externí odkaz:
https://doaj.org/article/079aae328c57494c8eacb9d2bc3db5b2